A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice-Reference-Cited by-同舟云学术

A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice

Published:2016-09-26 Issue:2 Volume:98 Page:112-120
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Steurer Michael¹,Quittet Philippe²,Papadaki Helen A.³,Selleslag Dominik⁴,Viallard Jean-François⁵,Kaiafa Georgia⁶,Janssens Ann⁷,Kozak Tomas⁸,Wadenvik Hans⁹,Schoonen Marieke¹⁰,Belton Laura¹¹,Kreuzbauer Georg¹²

Affiliation:

1. Division of Haematology and Oncology; Innsbruck Medical University; Innsbruck Austria

2. Haematology Department; Hôpital Saint Eloi; Montpellier France

3. Department of Haematology; University of Crete School of Medicine; University Hospital of Heraklion; Crete Greece

4. Department of Haematology; A-Z Sint-Jan; Bruges-Oostende Belgium

5. Hôpital du Haut Lévèque; University of Bordeaux; Pessac France

6. AHEPA University General Hospital; Medical Propedeutic Department of Internal Medicine; Aristotle University of Thessaloniki; Thessaloniki Greece

7. Department of Haematology; University Hospitals Leuven; Leuven Belgium

8. 3rd Medical Faculty; Charles University; Prague Czech Republic

9. Section of Haematology; Sahlgrenska University Hospital; Gothenburg Sweden

10. Center for Observational Research; Uxbridge UK

11. Biostatistics; LB Biostatistics; London UK

12. International Medical Development and Research; Amgen (Europe) GmbH; Zug Switzerland

Funder

Amgen

Novartis

Bristol-Myers Squibb

GlaxoSmithKline

Alexion Pharmaceuticals

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12807/fullpdf

Reference22 articles.

1. International consensus report on the investigation and management of primary immune thrombocytopenia;Provan;Blood,2010

2. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group;Rodeghiero;Blood,2009

3. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia;Neunert;Blood,2011

4. Development of romiplostim for the treatment of patients with chronic immune thrombocytopenia: from bench to bedside;Molineux;Br J Haematol,2010

5. Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study;Newland;Br J Haematol,2016

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune thrombocytopenia: Pathophysiology and impacts of Romiplostim treatment;Blood Reviews;2024-09

2. Thrombopoietin-receptor agonists for adult patients with immune thrombocytopenia: a narrative review and an approach for managing patients fasting intermittently;Frontiers in Cardiovascular Medicine;2023-12-14

3. Risk of thrombotic events in immune thrombocytopenia patients treated with thrombopoietic agents: a systematic review and meta-analysis;Thrombosis Journal;2023-06-23

4. Generic romiplostim for children with persistent or chronic immune thrombocytopenia: Experience from a tertiary care centre in North India;British Journal of Haematology;2022-04-25

5. Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and Perspectives;Therapeutics and Clinical Risk Management;2022-03